Referenser

  1. Shackleton C. Steroid analysis and doping control 1960-1980: scientific developments and personal anecdotes. Steroids. 2009;74(3):288-95.

  2. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1-7.

  3. Hirschberg AL, Elings Knutsson J, Helge T, Godhe M, Ekblom M, Bermon S, et al. Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study. Br J Sports Med. 2020;54(10):599-604.

  4. Kolliari-Turner A, Lima G, Wang G, Malinsky FR, Karanikolou A, Eichhorn G, et al. An observational human study investigating the effect of anabolic androgenic steroid use on the transcriptome of skeletal muscle and whole blood using RNA-Seq. BMC Med Genomics. 2023;16(1):94.

  5. Palonek E, Ericsson M, Garevik N, Rane A, Lehtihet M, Ekstrom L. Atypical excretion profile and GC/C/IRMS findings may last for nine months after a single dose of nandrolone decanoate. Steroids. 2016;108:105-11.

  6. Strahm E, Mullen JE, Garevik N, Ericsson M, Schulze JJ, Rane A, et al. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. Drug Test Anal. 2015;7(11-12):1063-70.

  7. Knutsson JE, Ekstrom L, Hirschberg AL. Disposition of serum steroids in response to combined oral contraceptives and menstrual cycle phases: A double-blind, randomized, placebo-controlled study. Drug Test Anal. 2023;15(1):134-8.

  8. Salamin O, Nicoli R, Langer T, Boccard J, Grundisch CS, Xu C, et al. Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle. Drug Test Anal. 2022;14(5):833-50.

  9. Geyer H, Parr MK, Koehler K, Mareck U, Schanzer W, Thevis M. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008;43(7):892-902.

  10. Choo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. Am J Physiol. 1992;263(1 Pt 1):E50-6.

  11. Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019;7(1):84-94.

  12. Haile DW, Durussel J, Mekonen W, Ongaro N, Anjila E, Mooses M, et al. Effects of EPO on Blood Parameters and Running Performance in Kenyan Athletes. Med Sci Sports Exerc. 2019;51(2):299-307.

  13. Hostrup M, Kalsen A, Auchenberg M, Bangsbo J, Backer V. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes. Scand J Med Sci Sports. 2016;26(1):8-16.

  14. Ide V, Vanderschueren D, Antonio L. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy. Int J Mol Sci. 2020;22(1).

  15. Schumacher YO, Pottgiesser T, Ahlgrim C, Ruthardt S, Dickhuth HH, Roecker K. Haemoglobin mass in cyclists during stage racing. Int J Sports Med. 2008;29(5):372-8.

  16. Baoutina A, Coldham T, Fuller B, Emslie KR. Improved detection of transgene and nonviral vectors in blood. Hum Gene Ther Methods. 2013;24(6):345-54.

  17. Mauger AR, Thomas T, Smith SA, Fennell CRJ. Tramadol is a performance-enhancing drug in highly trained cyclists: a randomized controlled trial. J Appl Physiol (1985). 2023;135(2):467-74.

  18. Vernec A, Slack A, Harcourt PR, Budgett R, Duclos M, Kinahan A, et al. Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review. Br J Sports Med. 2020;54(1):8-12.

  19. Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383-98.

  20. Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022;13:1059473.

  21. Smit DL, Bond P, de Ronde W. Health effects of androgen abuse: a review of the HAARLEM study. Curr Opin Endocrinol Diabetes Obes. 2022;29(6):560-5.

  22. Flanagan JN, Lehtihet M. The Response to Gonadotropin-Releasing Hormone and hCG in Men with Prior Chronic Androgen Steroid Abuse and Clinical Hypogonadism. Horm Metab Res. 2015;47(9):668-73.

  23. Bohlin KP, Pohanka A, Andersson A, Villen T, Ekstrom L. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport. Drug Test Anal. 2023.

  24. Anawalt BD. Diagnosis and Management of Anabolic Androgenic Steroid Use. J Clin Endocrinol Metab. 2019;104(7):2490-500.

  25. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-44.

Föregående sida
Behandling

Nästa sida
Tillbaka till kapitlets första sida